Skip to main content
. Author manuscript; available in PMC: 2019 Nov 6.
Published in final edited form as: J Thorac Oncol. 2018 Jul 17;13(9):1393–1399. doi: 10.1016/j.jtho.2018.05.002

Table 1.

Baseline Demographics

Characteristic n (%) (N = 45)
Median age, y (range) 66 (50–86)
Sex
 Male 20 (44)
 Female 25 (56)
Race
 White 37 (82)
 Black 6 (13)
 Other 2 (5)
Current or former smoker 44 (98)
Brain metastases 10 (22)
Chemotherapy cycles
 4 23 (51)
 5–6 22 (49)
Median time to first dose of pembrolizumab, wk (range) 5 (3–9)
Measurable disease 34 (76)